Page 249 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg
P. 249
References
1. Roche. Analysis of CYP2D6 and CYP2C19 genes. [Website]. 2009; https://web.archive.org/ web/20110906084820/http://molecular.roche.com:80/assays/Pages/AmpliChipCYP450Test. aspx. Accessed 05 May 2017.
2. Bank PC, Swen JJ, Guchelaar HJ, Van der Straaten T. GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population. Pharmacogenomics. 2015;16(7):681-687.
3. Luminex. xTAG® CYP2D6 Kit v3. https://www.luminexcorp.com/eu/cyp2d6/. Accessed November 22, 2017.
4. AutoGenomics. INFINITI CYP450 2D6-BC Assay. http://www.autogenomics.com/?q=node/204. Accessed November 22, 2017.
5. Rogers JF, Nafziger AN, Bertino JS, Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med. 2002;113(9):746-750.
6. Henricks LM, Lunenburg CATC, Meulendijks D, et al. Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score. Pharmacogenomics. 2015;16(11):1277-1286.
7. Brunham LR, Lansberg PJ, Zhang L, et al. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J. 2012;12(3):233- 237.
8. Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on 9 the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet. 2010;49(3):141-175.
9. Pirmohamed M, Burnside G, Eriksson N, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013;369(24):2294-2303.
10. Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35(1):15-36.
11. Ten Brink MH, Bouwsma H, Baak-Pablo R, Guchelaar HJ, Van der Straaten T, Swen JJ. PKP- 016 Pharmacogenetics in allogeneic stem cell transplant patients: Mind the Mix Eur J Hosp Pharm. 2014;21(A143).
12. Ten Brink MH, Van der Straaten T, Bouwsma H, Baak-Pablo R, Guchelaar HJ, Swen JJ. Pharmacogenetics in transplant patients: mind the mix. Clin Pharmacol Ther. 2013;94(4):443- 444.
13. Rasmussen HB, Werge T. Novel variant of CYP2D6*6 is undetected by a commonly used genotyping procedure. Pharmacol Rep. 2011;63(5):1264-1266.
Supplement
247
